{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T09:15:19Z","timestamp":1785575719182,"version":"3.56.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.dsx.2021.01.016","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T03:35:38Z","timestamp":1611372938000},"page":"361-363","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Low carbohydrate diet while taking dapagliflozin: A case report and review of literature"],"prefix":"10.1016","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3121-8040","authenticated-orcid":false,"given":"Namrata","family":"Paul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Jonklaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.dsx.2021.01.016_bib1","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s13300-014-0089-4","article-title":"Sodium glucose Co-Transporter-2 (SGLT2) inhibitors: a review of their basic and clinical pharmacology [published correction appears in diabetes ther. 2015 mar;6(1):95]","volume":"5","author":"Kalra","year":"2014","journal-title":"Diabetes Ther"},{"issue":"8","key":"10.1016\/j.dsx.2021.01.016_bib2","article-title":"Sodium-glucose linked transporter inhibitors as a cause of euglycemic diabetic ketoacidosis on a background of starvation","volume":"12","author":"Tauseef","year":"2020","journal-title":"Cureus. 2020"},{"key":"10.1016\/j.dsx.2021.01.016_bib3","first-page":"8832833","article-title":"A\u00a0case of diabetic ketoacidosis in a patient on an SGLT2 inhibitor and a ketogenic diet: a critical trio not to Be missed","volume":"2020","author":"Steinmetz-Wood","year":"2020","journal-title":"Case Rep Endocrinol. 2020"},{"issue":"2","key":"10.1016\/j.dsx.2021.01.016_bib4","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/phar.1881","article-title":"SGLT2 inhibitors: a systematic review of diabetic ketoacidosis and related risk factors in the primary literature","volume":"37","author":"Burke","year":"2017","journal-title":"Pharmacotherapy"},{"issue":"5","key":"10.1016\/j.dsx.2021.01.016_bib5","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/jdi.12330","article-title":"Case of ketoacidosis by a sodium-glucose cotransporter 2 inhibitor in a diabetic patient with a low-carbohydrate diet","volume":"6","author":"Hayami","year":"2015","journal-title":"J\u00a0Diabetes Investig"},{"issue":"10","key":"10.1016\/j.dsx.2021.01.016_bib6","doi-asserted-by":"crossref","first-page":"e165","DOI":"10.2337\/dc16-0728","article-title":"A\u00a0case of euglycemic diabetic ketoacidosis following long-term empagliflozin therapy","volume":"39","author":"Farjo","year":"2016","journal-title":"Diabetes Care"},{"issue":"9","key":"10.1016\/j.dsx.2021.01.016_bib7","first-page":"745","article-title":"Effect of sodium glucose cotransporter 2 inhibitors with low SGLT2\/SGLT1 selectivity on circulating glucagon-like peptide 1 levels in type 2 diabetes mellitus","volume":"9","author":"Takebayashi","year":"2017","journal-title":"J\u00a0Clin Med Res"},{"issue":"1","key":"10.1016\/j.dsx.2021.01.016_bib8","article-title":"Euglycemic diabetic ketoacidosis due to a strict low-carbohydrate diet during treatment with sodium-glucose cotransporter 2 inhibitors","volume":"7","author":"Fukuyama","year":"2020","journal-title":"Acute Med Surg. 2020"},{"key":"10.1016\/j.dsx.2021.01.016_bib9","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121000187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:12:05Z","timestamp":1761729125000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121000187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1871402121000187"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.01.016","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low carbohydrate diet while taking dapagliflozin: A case report and review of literature","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.01.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd on behalf of Diabetes India.","name":"copyright","label":"Copyright"}]}}